JP2016513651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513651A5 JP2016513651A5 JP2016502107A JP2016502107A JP2016513651A5 JP 2016513651 A5 JP2016513651 A5 JP 2016513651A5 JP 2016502107 A JP2016502107 A JP 2016502107A JP 2016502107 A JP2016502107 A JP 2016502107A JP 2016513651 A5 JP2016513651 A5 JP 2016513651A5
- Authority
- JP
- Japan
- Prior art keywords
- mol
- composition
- lipid
- cisplatin
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780272P | 2013-03-13 | 2013-03-13 | |
| US61/780,272 | 2013-03-13 | ||
| PCT/US2014/026341 WO2014160337A1 (en) | 2013-03-13 | 2014-03-13 | Liposomal cisplatin compositions for cancer therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016513651A JP2016513651A (ja) | 2016-05-16 |
| JP2016513651A5 true JP2016513651A5 (enExample) | 2016-12-22 |
| JP6077710B2 JP6077710B2 (ja) | 2017-02-08 |
Family
ID=50439522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502107A Expired - Fee Related JP6077710B2 (ja) | 2013-03-13 | 2014-03-13 | がん療法のためのリポソームシスプラチン組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10039716B2 (enExample) |
| EP (1) | EP2968142A1 (enExample) |
| JP (1) | JP6077710B2 (enExample) |
| CN (1) | CN105209017A (enExample) |
| BR (1) | BR112015022415A2 (enExample) |
| CA (1) | CA2903254C (enExample) |
| MX (1) | MX2015012199A (enExample) |
| WO (1) | WO2014160337A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5994049B2 (ja) * | 2012-10-01 | 2016-09-21 | 兵神装備株式会社 | 吐出システム |
| WO2016141167A1 (en) | 2015-03-03 | 2016-09-09 | Cureport, Inc. | Combination liposomal pharmaceutical formulations |
| CA2977397A1 (en) * | 2015-03-03 | 2016-09-09 | Cureport, Inc. | Dual loaded liposomal pharmaceutical formulations |
| US20170049701A1 (en) * | 2015-08-05 | 2017-02-23 | Steven M. Kushner | Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients |
| US20180344644A1 (en) * | 2015-09-21 | 2018-12-06 | Mallinckrodt Llc | Improved stability of liposome formulations and uses thereof |
| PH12022550592A1 (en) * | 2016-01-07 | 2023-07-17 | Tesorx Pharma Llc | Formulations for treating bladder cancer |
| WO2017142876A1 (en) | 2016-02-15 | 2017-08-24 | University Of Georgia Research Foundation, Inc. | lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF |
| KR102483033B1 (ko) * | 2016-05-16 | 2022-12-30 | 액세스 투 어드밴스드 헬스 인스티튜트 | 페길화된 리포솜 및 이의 용도 |
| CA3050686A1 (en) * | 2017-01-18 | 2018-07-26 | Temasek Life Sciences Laboratory Limited | Hyperstabilized liposomes increase targeting of mitotic cells |
| EP3706801B1 (en) * | 2017-11-08 | 2026-01-14 | L.E.A.F Holdings Group LLC | Platinum complexes and uses thereof |
| WO2021183588A1 (en) | 2020-03-10 | 2021-09-16 | Chung Yuan Christian University | Liposome composition and preparation method thereof |
| TW202345843A (zh) * | 2022-04-06 | 2023-12-01 | 財團法人國家衛生研究院 | 脂質奈米顆粒及脂質體 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843473A (en) * | 1989-10-20 | 1998-12-01 | Sequus Pharmaceuticals, Inc. | Method of treatment of infected tissues |
| US20020009488A1 (en) * | 1995-05-03 | 2002-01-24 | Polymasc Pharmaceuticals Plc | Tissue entrapment |
| ATE252372T1 (de) * | 1996-08-23 | 2003-11-15 | Sequus Pharm Inc | Liposome enthaltend cisplatin |
| EA002630B1 (ru) | 1997-02-05 | 2002-08-29 | Фармация Энд Апджон Компани | Способ получения липидных комплексов или липосом водонерастворимого диаминоциклогександикарбоксилата платины |
| DE60110057T2 (de) * | 2000-01-28 | 2005-09-08 | Alza Corp., Mountain View | Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung |
| AU2002225878A1 (en) * | 2000-11-02 | 2002-05-15 | Smith Kline Beecham Corporation | Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| DE60222580T2 (de) * | 2001-11-13 | 2008-06-12 | Celator Pharmaceuticals, Inc. | Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung |
| EP1674081A1 (de) * | 2004-12-23 | 2006-06-28 | KTB Tumorforschungsgesellschaft mbH | Herstellung von lipidbasierten Nanopartikeln unter Einsatz einer dualen asymmetrischen Zentrifuge |
| JP2006248978A (ja) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
| EP1716870A1 (en) * | 2005-04-29 | 2006-11-02 | Bracco Imaging S.p.A. | MRI contrast agents endowed with concentration independent responsiveness |
| JP5364381B2 (ja) | 2006-12-08 | 2013-12-11 | 片山化学工業株式会社 | アンミン白金錯体を高濃度で内包するリポソームおよびその製造方法 |
-
2014
- 2014-03-13 CA CA2903254A patent/CA2903254C/en not_active Expired - Fee Related
- 2014-03-13 WO PCT/US2014/026341 patent/WO2014160337A1/en not_active Ceased
- 2014-03-13 CN CN201480026589.0A patent/CN105209017A/zh active Pending
- 2014-03-13 US US14/208,297 patent/US10039716B2/en not_active Expired - Fee Related
- 2014-03-13 EP EP14715517.0A patent/EP2968142A1/en not_active Withdrawn
- 2014-03-13 JP JP2016502107A patent/JP6077710B2/ja not_active Expired - Fee Related
- 2014-03-13 BR BR112015022415A patent/BR112015022415A2/pt not_active IP Right Cessation
- 2014-03-13 MX MX2015012199A patent/MX2015012199A/es unknown
-
2018
- 2018-07-09 US US16/030,575 patent/US10383823B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10842745B2 (en) | Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same | |
| JP6263508B2 (ja) | 疾患修飾性抗リウマチ薬（ｄｍａｒｄ）および抗癌剤としてのメトトレキサートの持続性放出製剤 | |
| JP2019006815A5 (enExample) | ||
| RU2014120216A (ru) | Комбинационные липосомальные композиции для лечения рака | |
| JP2014532665A5 (enExample) | ||
| JP6893245B2 (ja) | 脂質ナノ粒子用膜材料組成物 | |
| WO2010009186A1 (en) | Liposome formulation having hydrophilic and hydrophobic pharmaceutical compounds co-encapsulated therein | |
| JP6077710B2 (ja) | がん療法のためのリポソームシスプラチン組成物 | |
| JP2014506918A (ja) | 抗腫瘍活性物質を含むリポソーム製剤、その調製のための方法、及び、それを含む医薬組成物 | |
| JP2019516693A5 (enExample) | ||
| JP2018527335A5 (enExample) | ||
| CN107708670A (zh) | 磷脂包衣的治疗剂纳米颗粒和有关的方法 | |
| JP2009513621A (ja) | リポソームを調製する方法及びその使用 | |
| Porte et al. | A molecular view of lipid nanoparticles: insights into their morphology and structural plasticity | |
| JP2018500359A (ja) | 表皮成長因子とリポソームのハイブリッド型多層ナノ構造体及びその製造方法 | |
| EP2231190B1 (en) | Particulate drug carriers as desensitizing agents | |
| CN114652683A (zh) | 一种Mdivi-1纳米长循环脂质体及其制备方法和应用 | |
| JP6322575B2 (ja) | 脂質マイクロカプセルのデリバリービヒクルを含む局所用製剤およびその使用 | |
| JP7590774B2 (ja) | リポソームドキソルビシン製剤、リポソームドキソルビシン製剤の製造方法、および薬剤としてのリポソームドキソルビシン製剤の使用 | |
| US20160175250A1 (en) | Method for Making Liposomes Containing an Active Pharmaceutical Ingredient | |
| TWI391149B (zh) | 小粒徑聚乙二醇化微脂體及其製備方法 | |
| WO2026088039A1 (en) | Encapsulated apomorphine compositions | |
| TW202302073A (zh) | 包含帶電脂質的脂質製劑的組合物及製備方法 | |
| WO2016013031A1 (en) | Liposome composition and method of preparing the liposome | |
| WO2013131164A1 (pt) | Composição farmacêutica contendo lipossomas convencionais e lipossomas de circulação prolongada para o tratamento da leishmaniose visceral |